Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE: 000766)
China
· Delayed Price · Currency is CNY
15.17
-0.28 (-1.81%)
Jan 3, 2025, 3:04 PM CST
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Operating Revenue | 1,473 | 1,473 | 1,470 | 1,514 | 1,111 | 1,974 | Upgrade
|
Other Revenue | - | - | 0.58 | 1.32 | 0.72 | 3.38 | Upgrade
|
Revenue | 1,473 | 1,473 | 1,471 | 1,515 | 1,112 | 1,977 | Upgrade
|
Revenue Growth (YoY) | 0.18% | 0.18% | -2.95% | 36.31% | -43.77% | -5.60% | Upgrade
|
Cost of Revenue | 379.14 | 379.14 | 352.93 | 350.18 | 229.94 | 343.84 | Upgrade
|
Gross Profit | 1,094 | 1,094 | 1,118 | 1,165 | 881.86 | 1,633 | Upgrade
|
Selling, General & Admin | 905 | 905 | 923.47 | 986.24 | 1,042 | 1,458 | Upgrade
|
Research & Development | 45.82 | 45.82 | 64.91 | 63.52 | 50.33 | 66.91 | Upgrade
|
Other Operating Expenses | -0.02 | -0.02 | 5.52 | 5.4 | 3.96 | 20.99 | Upgrade
|
Operating Expenses | 950.8 | 950.8 | 990.81 | 1,052 | 1,228 | 1,590 | Upgrade
|
Operating Income | 143.41 | 143.41 | 127.01 | 113.33 | -346.24 | 43.78 | Upgrade
|
Interest Expense | - | - | -88.79 | -97.19 | -125.27 | -48.79 | Upgrade
|
Interest & Investment Income | - | - | 11.5 | 26.36 | 23.31 | 20.47 | Upgrade
|
Other Non Operating Income (Expenses) | -83.7 | -83.7 | -3.64 | 3.47 | -0.37 | 6.5 | Upgrade
|
EBT Excluding Unusual Items | 59.71 | 59.71 | 46.08 | 45.98 | -448.58 | 21.95 | Upgrade
|
Impairment of Goodwill | - | - | - | - | - | -2,056 | Upgrade
|
Gain (Loss) on Sale of Investments | -2.61 | -2.61 | -0.05 | -0.01 | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | -0.21 | -0.21 | -0.02 | 0.83 | 57.58 | -0 | Upgrade
|
Asset Writedown | -2.03 | -2.03 | -0.11 | -1.49 | -0.43 | -15.01 | Upgrade
|
Other Unusual Items | - | - | 4.28 | 14.32 | 35.6 | 36.63 | Upgrade
|
Pretax Income | 54.86 | 54.86 | 50.17 | 59.62 | -355.83 | -2,013 | Upgrade
|
Income Tax Expense | 11.63 | 11.63 | 20.99 | 25.64 | 4.83 | 30.19 | Upgrade
|
Earnings From Continuing Operations | 43.23 | 43.23 | 29.19 | 33.99 | -360.66 | -2,043 | Upgrade
|
Minority Interest in Earnings | 0.71 | 0.71 | 0.96 | 1.29 | 1.16 | 1.05 | Upgrade
|
Net Income | 43.93 | 43.93 | 30.15 | 35.27 | -359.5 | -2,042 | Upgrade
|
Net Income to Common | 43.93 | 43.93 | 30.15 | 35.27 | -359.5 | -2,042 | Upgrade
|
Net Income Growth | 45.71% | 45.71% | -14.52% | - | - | - | Upgrade
|
Shares Outstanding (Basic) | 879 | 879 | 1,005 | 882 | 972 | 968 | Upgrade
|
Shares Outstanding (Diluted) | 879 | 879 | 1,005 | 882 | 972 | 968 | Upgrade
|
Shares Change (YoY) | -12.57% | -12.57% | 13.97% | -9.24% | 0.40% | 0.13% | Upgrade
|
EPS (Basic) | 0.05 | 0.05 | 0.03 | 0.04 | -0.37 | -2.11 | Upgrade
|
EPS (Diluted) | 0.05 | 0.05 | 0.03 | 0.04 | -0.37 | -2.11 | Upgrade
|
EPS Growth | 66.67% | 66.67% | -25.00% | - | - | - | Upgrade
|
Free Cash Flow | 86.11 | 86.11 | 174.42 | 112.85 | 61.55 | 13.88 | Upgrade
|
Free Cash Flow Per Share | 0.10 | 0.10 | 0.17 | 0.13 | 0.06 | 0.01 | Upgrade
|
Gross Margin | 74.27% | 74.27% | 76.00% | 76.89% | 79.32% | 82.61% | Upgrade
|
Operating Margin | 9.73% | 9.73% | 8.64% | 7.48% | -31.14% | 2.21% | Upgrade
|
Profit Margin | 2.98% | 2.98% | 2.05% | 2.33% | -32.33% | -103.27% | Upgrade
|
Free Cash Flow Margin | 5.84% | 5.84% | 11.86% | 7.45% | 5.54% | 0.70% | Upgrade
|
EBITDA | 218.14 | 218.14 | 198.19 | 182.72 | -278.53 | 111.62 | Upgrade
|
EBITDA Margin | 14.81% | 14.81% | 13.48% | 12.06% | -25.05% | 5.65% | Upgrade
|
D&A For EBITDA | 74.74 | 74.74 | 71.18 | 69.39 | 67.71 | 67.84 | Upgrade
|
EBIT | 143.41 | 143.41 | 127.01 | 113.33 | -346.24 | 43.78 | Upgrade
|
EBIT Margin | 9.73% | 9.73% | 8.64% | 7.48% | -31.14% | 2.21% | Upgrade
|
Effective Tax Rate | 21.20% | 21.20% | 41.82% | 43.00% | - | - | Upgrade
|
Revenue as Reported | - | - | 1,471 | 1,515 | 1,112 | 1,977 | Upgrade
|
Advertising Expenses | - | - | 298.68 | 375.06 | 299.1 | 321.82 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.